U.S. Basic Materials Stock News

NYSE:ALLE
NYSE:ALLEBuilding

Assessing Allegion (ALLE) Valuation After Recent Share Price Weakness

Why Allegion’s recent performance is drawing attention Allegion (ALLE) has been on many investors’ screens after a recent stretch of weaker share performance, with the stock down over the past week, month and past 3 months. At a last close of US$150.37, Allegion’s move contrasts with its positive 1 year and multi year total returns. This is prompting some investors to reassess how its current valuation lines up with its security hardware and access control business profile. See our latest...
NYSE:ANF
NYSE:ANFSpecialty Retail

Abercrombie And Fitch Reworks APAC Presence While Adding US Store Growth

Abercrombie & Fitch (NYSE:ANF) has begun a review of its Asia Pacific operations that could include new partnerships, franchising, or licensing structures. The company is also expanding its US footprint with a new store at Town Center of Virginia Beach, a major mixed use retail destination. For investors watching NYSE:ANF, these moves come with the stock at $85.0 after a 31.3% decline year to date and a 19.5% decline over the past month. Even with recent weakness, the 3 year return is...
NYSE:RVLV
NYSE:RVLVSpecialty Retail

Revolve Group RVLV Valuation Check As Revolve Los Angeles Expands High End Fashion Offerings

Revolve Los Angeles launch puts new spotlight on RVLV stock Revolve Group (RVLV) just announced Revolve Los Angeles, its first namesake fashion house, focusing on luxury ready to wear and couture level pieces priced between $200 and $3,500, exclusively on Revolve and FWRD. See our latest analysis for Revolve Group. Revolve Group shares now trade at US$25.23, with a 1 day share price return of a 1.29% decline and a year to date share price return of a 14.65% decline. The 1 year total...
NYSE:ZETA
NYSE:ZETASoftware

Zeta Global Athena Launch Puts AI Growth Goals And Valuation In Focus

Zeta Global Holdings (NYSE:ZETA) introduced Athena, a conversational AI agent, as part of its marketing platform. The company described Athena as a tool to help customers increase engagement and simplify how they use Zeta's products. Management also highlighted ongoing customer expansion and expressed ambitions to grow market share and wallet share through deeper AI integration and proprietary data. Zeta Global operates as a marketing technology provider, focused on using data and AI to...
NYSE:SBR
NYSE:SBROil and Gas

A Look At Sabine Royalty Trust (SBR) Valuation After Higher Monthly Distribution On Stronger Production And Pricing

Sabine Royalty Trust (SBR) is back in focus after Argent Trust Company declared a higher monthly cash distribution of $0.286230 per unit, supported by recently reported production volumes and current commodity pricing. See our latest analysis for Sabine Royalty Trust. The higher March cash distribution and the latest production update come after a year where the unit price has been relatively steady in the short term. Over that period, Sabine Royalty Trust has delivered an 18.5% 1 year total...
NYSE:FRO
NYSE:FROOil and Gas

A Look At Frontline (NYSE:FRO) Valuation After Strong Q4 Earnings, Dividend Payout And Options Activity

Frontline (FRO) is in focus after reporting fourth quarter and full year 2025 results, announcing a US$1.03 per share dividend for the quarter, and drawing attention through increased options trading activity. See our latest analysis for Frontline. Alongside the dividend, earnings and board changes, Frontline’s share price has been volatile, with a 30 day share price return of 22.55% and a 90 day share price return of 47.82%. Its 1 year total shareholder return of 118.48% and 5 year total...
NasdaqGM:LGND
NasdaqGM:LGNDPharmaceuticals

A Look At Ligand Pharmaceuticals (LGND) Valuation After Profitability Return And Reaffirmed 2026 Guidance

Ligand Pharmaceuticals (LGND) is back in focus after reporting quarterly and full year 2025 results that moved from loss to profit, reaffirming 2026 revenue guidance and filing new shelf and at the market equity programs. See our latest analysis for Ligand Pharmaceuticals. Ligand’s recent swing to profitability, reaffirmed 2026 revenue guidance and fresh shelf and at the market programs have come after a period of solid momentum. The current US$201.90 share price sits against a 90 day share...
NasdaqGS:ALKT
NasdaqGS:ALKTSoftware

A Look At Alkami Technology (ALKT) Valuation After SDK Wizard Update And Nacha Preferred Partner Recognition

Alkami Technology (ALKT) is back in focus after rolling out Automated Stage Match in its SDK Wizard, a product update aimed at speeding up development for financial institution clients and simplifying how teams test new features. See our latest analysis for Alkami Technology. The latest SDK update lands after a busy few weeks that included Alkami’s Nacha Preferred Partner recognition and full year 2025 results. The 1 day share price return of 3.4% comes against a year to date share price...
NYSE:FICO
NYSE:FICOSoftware

A Look At Fair Isaac (FICO) Valuation After The New US$1.5b Share Repurchase Program

Fair Isaac (FICO) has put a fresh US$1.5b share repurchase authorization in place after completing a prior US$1b program, with about US$181 million already bought back this quarter at a last close near US$1,476. See our latest analysis for Fair Isaac. Despite the fresh buyback authorization and a series of credit education and product announcements, the share price has had a mixed run, with a 7 day share price return of 4.73% and a 90 day share price return of a 17.93% decline, while the 5...
NasdaqGS:COGT
NasdaqGS:COGTBiotechs

Is 48-Week Bezuclastinib Data in Systemic Mastocytosis Altering The Investment Case For Cogent Biosciences (COGT)?

Cogent Biosciences recently reported additional clinical results from its pivotal SUMMIT trial of bezuclastinib in NonAdvanced Systemic Mastocytosis, showing rapid, durable and statistically significant improvements in symptoms, disease biomarkers and bone mineral density over 48 weeks. The new data also suggest potential disease modification and meaningful benefit for patients with high unmet need, reinforcing bezuclastinib’s clinical relevance in this rare mast cell disorder. We’ll now...
NYSE:CBL
NYSE:CBLRetail REITs

How Investors May Respond To CBL & Associates Properties (CBL) Buying Gateway Mall And Selling A Non-Core Center

CBL & Associates Properties recently acquired Gateway Mall, a market-dominant enclosed shopping center in Lincoln, Nebraska, while agreeing to sell a non-core open-air center as part of its portfolio reshaping efforts. This combination of acquiring a higher-yield enclosed mall and recycling capital from an asset sale highlights the company’s focus on enhancing cash-flow quality and refining its retail mix. We’ll now examine how this capital recycling into higher-yield malls could influence...
NasdaqGS:MBLY
NasdaqGS:MBLYAuto Components

Assessing Mobileye Global (MBLY) Valuation After Q4 Revenue Beat And Softer Full Year Outlook

Q4 earnings beat meets cautious outlook Mobileye Global (MBLY) recently reported quarterly revenue that came in ahead of expectations, while its full-year revenue guidance landed below what analysts were looking for, a mix that has quickly shaped market reaction. See our latest analysis for Mobileye Global. Mobileye’s recent update comes after a tough stretch for shareholders, with the share price at US$8.01 and a 30 day share price return of a 10.3% decline, contributing to a 1 year total...
NYSE:GOLD
NYSE:GOLDRetail Distributors

Is It Too Late To Consider Goldcom (GOLD) After Its 1-Year 95% Surge?

If you are wondering whether Gold.com is still attractively priced after its recent run, you are not alone. This article looks at what the current share price might be implying about value. The stock last closed at US$52.42, with returns of 1.8% over 30 days, 50.8% year to date, 95.0% over 1 year and 243.5% over 5 years, alongside an 8.8% decline over the past week that may have caught your attention. Recent coverage of Gold.com has focused on its share price performance and how investors...
NasdaqGS:RIVN
NasdaqGS:RIVNAuto

Rivian EnergyHub Deal Links EV Growth With Grid And Valuation Story

Rivian Automotive (NasdaqGS:RIVN) has entered a partnership with EnergyHub to expand access to utility managed charging programs for its drivers across North America. The collaboration connects Rivian vehicles with participating utilities, aiming to support smart grid integration and more efficient EV charging. The move positions Rivian within the broader energy management ecosystem, linking its EVs directly to grid friendly charging incentives and tools. Rivian, trading at $15.37, is...
NasdaqGS:GTLB
NasdaqGS:GTLBSoftware

GitLab (GTLB) Is Down 5.3% After Soft 2027 Outlook and New $400 Million Buyback - What's Changed

GitLab Inc. recently reported fourth-quarter and full-year 2026 results, showing revenue growth to US$260.4 million for the quarter and US$955.22 million for the year, alongside a modest quarterly net loss and fresh guidance for fiscal 2027 calling for US$253.0 million–US$255.0 million in first-quarter revenue and US$1.10 billion–US$1.12 billion for the full year. At the same time, the company authorized its first US$400 million share repurchase program, signaling management’s confidence in...
NYSE:TEL
NYSE:TELElectronic

TE Connectivity (TEL) Is Down 10.6% After Geopolitics Trump Strong Q1 Results And Guidance - Has The Bull Case Changed?

In early March 2026, TE Connectivity faced a broad market pullback tied to heightened geopolitical tensions in the Middle East and a risk-off shift among investors, even as the company reported strong first-quarter results, reaffirmed positive guidance, and declared a routine quarterly dividend. Amid this volatility, recent insider share sales under a pre-arranged Rule 10b5-1 plan and ongoing concerns about shipping costs and energy prices highlighted how external macro risks can...
NYSE:WPC
NYSE:WPCREITs

Does W. P. Carey (WPC) Offer Value After Recent Share Price Swings?

If you are wondering whether W. P. Carey at around US$72.61 is offering genuine value or just looks interesting on the surface, you are in the right place. The stock has been fairly active recently, with a 2.7% decline over the last 7 days, a 3.7% return over 30 days, 11.9% year to date, 18.6% over 1 year, 13.5% over 3 years and 43.0% over 5 years. Recent headlines around W. P. Carey have mainly focused on its position in the real estate sector and how investors are weighing its income...
NasdaqGS:JD
NasdaqGS:JDMultiline Retail

Reassessing JD.com (NasdaqGS:JD) Valuation After A Year Of Weak Shareholder Returns

Why JD.com (NasdaqGS:JD) is back on investors’ radar JD.com (NasdaqGS:JD) has drawn fresh attention after a period of weaker share performance, including a 34.2% negative total return over the past year, prompting investors to reassess how its current valuation lines up with its business fundamentals. See our latest analysis for JD.com. Recent trading has been choppy, with a 6.1% 1 day share price return and a 1.9% 7 day share price return, compared with a 90 day share price return of 9.6%...
NYSE:RTX
NYSE:RTXAerospace & Defense

A Look At RTX (RTX) Valuation As Defense Stocks Rally On Heightened Middle East Tensions

RTX (RTX) has moved into the spotlight after U.S. strikes on Iran sent defense stocks to fresh highs, with the White House now pressing major contractors to rapidly expand munitions production capacity. See our latest analysis for RTX. Beyond the immediate reaction to Middle East tensions, RTX’s 1 day share price return of 2.89% and 90 day share price return of 22.60% sit alongside a 1 year total shareholder return of 66.12%. This combination suggests momentum has been building over both...
NYSE:RJF
NYSE:RJFCapital Markets

A Look At Raymond James Financial (RJF) Valuation After Mixed Quarterly Results And Share Price Pullback

Raymond James Financial (RJF) is back in focus after a mixed quarterly update that paired record revenues and a maintained 20% adjusted pretax margin target with a post earnings share price pullback. See our latest analysis for Raymond James Financial. The recent earnings related pullback sits within a wider pattern where the 30 day share price return of 10.5% and year to date share price return of 7.06% contrast with a 1 year total shareholder return of 7.46% and a 5 year total shareholder...
NasdaqGS:SFM
NasdaqGS:SFMConsumer Retailing

Sprouts Farmers Market (SFM) Is Up 8.6% After US$1 Billion Buyback And Expansion Plans - What's Changed

Sprouts Farmers Market recently authorized a new US$1.00 billion share repurchase program, reported higher fourth-quarter fiscal 2025 net sales, and outlined plans to open more than 40 new stores in 2026. This combination of capital returns and physical expansion, alongside guidance for mid-single-digit total sales growth, highlights management’s confidence in Sprouts’ ability to fund growth while returning cash to shareholders. Next, we’ll examine how the US$1.00 billion buyback...
NasdaqGS:OZK
NasdaqGS:OZKBanks

Assessing Bank OZK (OZK) Valuation After Recent Share Price Pullback

Bank OZK stock snapshot Bank OZK (OZK) has been drawing attention after a recent share price pullback, with the stock showing negative returns over the past week, month and past 3 months, despite positive 1 year and multi year total returns. See our latest analysis for Bank OZK. The recent 9.9% 30 day share price decline and softer 90 day share price return sit against a 1 year total shareholder return of 2.9% and 3 year total shareholder return of 38%, suggesting momentum has cooled after...
NYSE:CVNA
NYSE:CVNASpecialty Retail

Carvana (CVNA) Valuation Check After Earnings Miss And Rising Loan Delinquency Concerns

What sparked the latest move in Carvana? Carvana (CVNA) shares moved after the company reported earnings that showed EBITDA underperformance related to higher reconditioning costs, as well as analyst target cuts and growing concern about rising loan delinquencies. See our latest analysis for Carvana. Those earnings related concerns have come after a powerful multi year run, with Carvana’s 1 year total shareholder return of 68.57% and very large 3 year total shareholder return, set against a...
NasdaqCM:VKTX
NasdaqCM:VKTXBiotechs

Is It Time To Reassess Viking Therapeutics (VKTX) After Its Recent Share Price Swings

Investors may be wondering whether Viking Therapeutics at around US$32.98 is starting to look attractively priced, or if most of the easy gains are already behind it. The stock has been choppy recently, with a 2.5% decline over the last 7 days, an 11.6% gain over 30 days, and a 6.9% decline year to date, while its 1 year return is 13.3% and its 3 year return is very large compared to its level three years ago. These swings have kept Viking on many investors' watchlists, as sentiment around...